{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T01:45:28Z","timestamp":1778809528546,"version":"3.51.4"},"reference-count":35,"publisher":"Impact Journals, LLC","issue":"78","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncotarget"],"published-print":{"date-parts":[[2018,10,5]]},"DOI":"10.18632\/oncotarget.26190","type":"journal-article","created":{"date-parts":[[2018,10,5]],"date-time":"2018-10-05T16:58:38Z","timestamp":1538758718000},"page":"34748-34764","source":"Crossref","is-referenced-by-count":19,"title":["Leukemia inhibitory factor via the Toll-like receptor 5 signaling pathway involves aggravation of cachexia induced by human gastric cancer-derived 85As2 cells in rats"],"prefix":"10.18632","volume":"9","author":[{"given":"Kiyoshi","family":"Terawaki","sequence":"first","affiliation":[{"name":"Division of Cancer Pathophysiology, National Cancer Center Research Institute, Chuo-Ku, Tokyo 104-0045, Japan"},{"name":"Tsumura Kampo Research Laboratories, Kampo Research & Development Division, Tsumura & Co., Inashiki-Gun, Ibaraki 300-1192, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yohei","family":"Kashiwase","sequence":"additional","affiliation":[{"name":"Division of Cancer Pathophysiology, National Cancer Center Research Institute, Chuo-Ku, Tokyo 104-0045, Japan"},{"name":"Laboratory of Molecular Pathology and Metabolic Disease, Faculty of Pharmaceutical Sciences, Tokyo University of Science, Noda, Chiba 278-8510, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miaki","family":"Uzu","sequence":"additional","affiliation":[{"name":"Division of Cancer Pathophysiology, National Cancer Center Research Institute, Chuo-Ku, Tokyo 104-0045, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miki","family":"Nonaka","sequence":"additional","affiliation":[{"name":"Division of Cancer Pathophysiology, National Cancer Center Research Institute, Chuo-Ku, Tokyo 104-0045, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yumi","family":"Sawada","sequence":"additional","affiliation":[{"name":"Division of Cancer Pathophysiology, National Cancer Center Research Institute, Chuo-Ku, Tokyo 104-0045, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kanako","family":"Miyano","sequence":"additional","affiliation":[{"name":"Division of Cancer Pathophysiology, National Cancer Center Research Institute, Chuo-Ku, Tokyo 104-0045, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshikazu","family":"Higami","sequence":"additional","affiliation":[{"name":"Laboratory of Molecular Pathology and Metabolic Disease, Faculty of Pharmaceutical Sciences, Tokyo University of Science, Noda, Chiba 278-8510, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuyoshi","family":"Yanagihara","sequence":"additional","affiliation":[{"name":"Division of Biomarker Discovery, Exploratory Oncology Research & Clinical Trial Center, National Cancer Center, Chiba 277-8577, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masahiro","family":"Yamamoto","sequence":"additional","affiliation":[{"name":"Tsumura Kampo Research Laboratories, Kampo Research & Development Division, Tsumura & Co., Inashiki-Gun, Ibaraki 300-1192, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuhito","family":"Uezono","sequence":"additional","affiliation":[{"name":"Division of Cancer Pathophysiology, National Cancer Center Research Institute, Chuo-Ku, Tokyo 104-0045, Japan"},{"name":"Division of Supportive Care Research, Exploratory Oncology Research & Clinica l Trial Center, National Cancer Center, Chuo-Ku, Tokyo 104-0045, Japan"},{"name":"Innovation Center for Supportive, Palliative and Phychosocial Care, National Cancer Center Hospital, Chuo-Ku, Tokyo 104-0045, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"7892","published-online":{"date-parts":[[2018,10,5]]},"reference":[{"key":"1","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1016\/j.clnu.2008.06.013","article-title":"Cachexia: a new definition","volume":"27","author":"Muscaritoli","year":"2008","journal-title":"Clin Nutr"},{"key":"2","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.ejca.2005.07.026","article-title":"Prevention and treatment of cancer cachexia: new insights into an old problem","volume":"42","author":"Rossi Fanelli","year":"2006","journal-title":"Eur J Cancer"},{"key":"3","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1038\/ncponc0112","article-title":"Therapy insight: Cancer anorexia-cachexia syndrome--when all you can eat is yourself","volume":"2","author":"Rossi-Fanelli","year":"2005","journal-title":"Nat Clin Pract Oncol"},{"key":"4","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1016\/j.clnu.2012.06.012","article-title":"The 2011 ESPEN Arvid Wretlind lecture: cancer cachexia: the potential impact of translational research on patient-focused outcomes","volume":"31","author":"Fearon","year":"2012","journal-title":"Clin Nutr"},{"key":"5","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1242\/dmm.008839","article-title":"Importance of functional and metabolic impairments in the characterization of the C-26 murine model of cancer cachexia","volume":"5","author":"Lynch","year":"2012","journal-title":"Dis Model Mech"},{"key":"6","doi-asserted-by":"publisher","first-page":"2409","DOI":"10.1007\/s00520-013-1800-0","article-title":"Effect of ghrelin and anamorelin (ONO-7643), a selective ghrelin receptor agonist, on tumor growth in a lung cancer mouse xenograft model","volume":"21","author":"Pietra","year":"2013","journal-title":"Support Care Cancer"},{"key":"7","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1080\/01635581.2013.776089","article-title":"Inhibitory effects of isoflavones on tumor growth and cachexia in newly established cachectic mouse models carrying human stomach cancers","volume":"65","author":"Seyama","year":"2013","journal-title":"Nutr Cancer"},{"key":"8","doi-asserted-by":"publisher","first-page":"E373","DOI":"10.1152\/ajpendo.00116.2013","article-title":"New cancer cachexia rat model generated by implantation of a peritoneal dissemination-derived human stomach cancer cell line","volume":"306","author":"Uezono","year":"2014","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"9","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S0165-2478(02)00228-6","article-title":"Recognition of pathogen-associated molecular patterns by TLR family","volume":"85","author":"Hemmi","year":"2003","journal-title":"Immunol Lett"},{"key":"10","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1038\/nri1391","article-title":"Toll-like receptor signalling","volume":"4","author":"Takeda","year":"2004","journal-title":"Nat Rev Immunol"},{"key":"11","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1038\/sj.cdd.4401850","article-title":"TLR signaling","volume":"13","author":"Akira","year":"2006","journal-title":"Cell Death Differ"},{"key":"12","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1146\/annurev.immunol.21.120601.141126","article-title":"Toll-like receptors","volume":"21","author":"Akira","year":"2003","journal-title":"Annu Rev Immunol"},{"key":"13","doi-asserted-by":"publisher","first-page":"1388","DOI":"10.1016\/j.micinf.2004.08.019","article-title":"Pleiotropic function of Toll-like receptors","volume":"6","author":"Akira","year":"2004","journal-title":"Microbes Infect"},{"key":"14","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1056\/NEJM200008033430506","article-title":"Innate immunity","volume":"343","author":"Janeway","year":"2000","journal-title":"N Engl J Med"},{"key":"15","first-page":"1","article-title":"Differential constitutive and cytokine-modulated expression of human Toll-like receptors in primary neutrophils, monocytes, and macrophages","volume":"5","author":"Liles","year":"2008","journal-title":"Int J Med Sci"},{"key":"16","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1002\/ijc.10632","article-title":"Lipopolysaccharide-induced metastatic growth is associated with increased angiogenesis, vascular permeability and tumor cell invasion","volume":"101","author":"Dong","year":"2002","journal-title":"Int J Cancer"},{"key":"17","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1111\/j.1600-0714.2010.00929.x","article-title":"Toll-like receptor 5 activation promotes migration and invasion of salivary gland adenocarcinoma","volume":"40","author":"Yoon","year":"2011","journal-title":"J Oral Pathol Med"},{"key":"18","doi-asserted-by":"publisher","first-page":"2909","DOI":"10.1158\/1078-0432.CCR-07-4467","article-title":"Helicobacter pylori augments growth of gastric cancers via the lipopolysaccharide-toll-like receptor 4 pathway whereas its lipopolysaccharide attenuates antitumor activities of human mononuclear cells","volume":"14","author":"Mochizuki","year":"2008","journal-title":"Clin Cancer Res"},{"key":"19","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1111\/j.1469-0691.2009.03031.x","article-title":"Helicobacter pylori and gastric adenocarcinoma","volume":"15","author":"Parsonnet","year":"2009","journal-title":"Clin Microbiol Infect"},{"key":"20","doi-asserted-by":"publisher","first-page":"4346","DOI":"10.1158\/0008-5472.CAN-06-4067","article-title":"Listeria monocytogenes promotes tumor growth via tumor cell toll-like receptor 2 signaling","volume":"67","author":"Feng","year":"2007","journal-title":"Cancer Res"},{"key":"21","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.ijmm.2005.02.009","article-title":"Toll-like receptors TLR4, TLR5 and TLR9 on gastric carcinoma cells: an implication for interaction with Helicobacter pylori","volume":"295","author":"Eck","year":"2005","journal-title":"Int J Med Microbiol"},{"key":"22","doi-asserted-by":"publisher","first-page":"32552","DOI":"10.1074\/jbc.M305536200","article-title":"Toll-like receptor (TLR) 2 and TLR5, but not TLR4, are required for Helicobacter pylori-induced NF-kappa B activation and chemokine expression by epithelial cells","volume":"278","author":"Goldberg","year":"2003","journal-title":"J Biol Chem"},{"key":"23","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1677\/joe.0.1790387","article-title":"Production of multiple cytokines and induction of cachexia in athymic nude mice by a new anaplastic thyroid carcinoma cell line","volume":"179","author":"Wang","year":"2003","journal-title":"J Endocrinol"},{"key":"24","doi-asserted-by":"publisher","first-page":"2727","DOI":"10.1002\/cncr.20672","article-title":"Cytokines in pancreatic carcinoma: correlation with phenotypic characteristics and prognosis","volume":"101","author":"Kurzrock","year":"2004","journal-title":"Cancer"},{"key":"25","first-page":"6656","article-title":"Cancer cachexia syndrome developed in nude mice bearing melanoma cells producing leukemia-inhibitory factor","volume":"51","author":"Abe","year":"1991","journal-title":"Cancer Res"},{"key":"26","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1152\/physrev.00016.2008","article-title":"Mechanisms of cancer cachexia","volume":"89","author":"Tisdale","year":"2009","journal-title":"Physiol Rev"},{"key":"27","first-page":"4493","article-title":"Cancer anorexia-cachexia syndrome: are neuropeptides the key?","volume":"59","author":"Inui","year":"1999","journal-title":"Cancer Res"},{"key":"28","doi-asserted-by":"publisher","first-page":"736563","DOI":"10.1155\/2014\/736563","article-title":"Effect of Sipjeondaebo-tang on cancer-induced anorexia and cachexia in CT-26 tumor-bearing mice","volume":"2014","author":"Ko","year":"2014","journal-title":"Mediators Inflamm"},{"key":"29","doi-asserted-by":"publisher","first-page":"E410","DOI":"10.1152\/ajpendo.00039.2012","article-title":"JAK\/STAT3 pathway inhibition blocks skeletal muscle wasting downstream of IL-6 and in experimental cancer cachexia","volume":"303","author":"Zimmers","year":"2012","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"30","doi-asserted-by":"publisher","first-page":"e1021542","DOI":"10.1080\/2162402X.2015.1021542","article-title":"TLR5 signaling, commensal microbiota and systemic tumor promoting inflammation: the three parcae of malignant progression","volume":"4","author":"Conejo-Garcia","year":"2015","journal-title":"Oncoimmunology"},{"key":"31","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.ccell.2014.11.009","article-title":"Microbially driven TLR5-dependent signaling governs distal malignant progression through tumor-promoting inflammation","volume":"27","author":"Tchou","year":"2015","journal-title":"Cancer Cell"},{"key":"32","doi-asserted-by":"publisher","first-page":"115","DOI":"10.3892\/ijmm.2011.656","article-title":"Flagellin promotes the proliferation of gastric cancer cells via the Toll-like receptor 5","volume":"28","author":"Park","year":"2011","journal-title":"Int J Mol Med"},{"key":"33","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1002\/ijc.20270","article-title":"CNTO 328, a monoclonal antibody to IL-6, inhibits human tumor-induced cachexia in nude mice","volume":"111","author":"Trikha","year":"2004","journal-title":"Int J Cancer"},{"key":"34","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1002\/syn.21559","article-title":"Changes in the melanocortin receptors in the hypothalamus of a rat model of cancer cachexia","volume":"66","author":"Uezono","year":"2012","journal-title":"Synapse"},{"key":"35","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2(\u2212Delta Delta C(T)) Method","volume":"25","author":"Schmittgen","year":"2001","journal-title":"Methods"}],"container-title":["Oncotarget"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.26190","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,9]],"date-time":"2020-05-09T19:39:20Z","timestamp":1589053160000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.26190"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10,5]]},"references-count":35,"journal-issue":{"issue":"78","published-print":{"date-parts":[[2018,10,5]]}},"alternative-id":["26190","30410674"],"URL":"https:\/\/doi.org\/10.18632\/oncotarget.26190","relation":{},"ISSN":["1949-2553"],"issn-type":[{"value":"1949-2553","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,10,5]]}}}